propidium has been researched along with 3,4,5-trihydroxybenzamidoxime in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elford, HL; Fritzer-Szekeres, M; Grusch, M; Horvath, S; Krupitza, G; Luxbacher, C; Szekeres, T | 1 |
1 other study(ies) available for propidium and 3,4,5-trihydroxybenzamidoxime
Article | Year |
---|---|
Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamidines; Bisbenzimidazole; Caspases; DNA Fragmentation; Enzyme Activation; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Fluorescent Dyes; Gelsolin; Gene Expression; Genes, myc; HL-60 Cells; Humans; Membrane Glycoproteins; Poly(ADP-ribose) Polymerases; Propidium; Ribonucleotide Reductases | 2000 |